Copyright
©The Author(s) 2017.
World J Crit Care Med. Feb 4, 2017; 6(1): 65-73
Published online Feb 4, 2017. doi: 10.5492/wjccm.v6.i1.65
Published online Feb 4, 2017. doi: 10.5492/wjccm.v6.i1.65
Variable | Univariate | P value | Multivariate | P value | |
NO-HK (n = 30) | No NO-HK (n = 29) | Adjusted OR (95%CI) | |||
Bolus hydrocortisone, n (%) | 12 (40) | 20 (69) | 0.02 | 8.5 (1.2-59.9) | 0.03 |
Hydrocortisone taper, n (%) | 17 (77.3) | 6 (30) | 0.002 | 10.6 (1.5-73.3) | 0.01 |
AKI, n (%) | 13 (43.3) | 18 (62.1) | 0.08 | 0.1 (0.01-0.8) | 0.03 |
Diuretic use, n (%) | 20 (66.7) | 10 (34.5) | 0.01 | 6.3 (0.95-42.0) | 0.05 |
- Citation: Ibarra-Estrada MA, Chávez-Peña Q, Reynoso-Estrella CI, Rios-Zermeño J, Aguilera-González PE, García-Soto MA, Aguirre-Avalos G. Timing, method and discontinuation of hydrocortisone administration for septic shock patients. World J Crit Care Med 2017; 6(1): 65-73
- URL: https://www.wjgnet.com/2220-3141/full/v6/i1/65.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v6.i1.65